A detailed history of Capital Planning Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 1,163 shares of LLY stock, worth $984,863. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,163
Previous 1,357 14.3%
Holding current value
$984,863
Previous $1.06 Million 0.28%
% of portfolio
0.19%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $140,624 - $176,353
-194 Reduced 14.3%
1,163 $1.05 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $2,368 - $3,169
-4 Reduced 0.29%
1,357 $1.06 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $29,935 - $35,290
-57 Reduced 4.02%
1,361 $793,000
Q2 2023

Aug 01, 2023

SELL
$350.74 - $468.98 $2,805 - $3,751
-8 Reduced 0.56%
1,418 $665,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $3,106 - $3,648
-10 Reduced 0.7%
1,426 $489,000
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $63,666 - $74,184
-198 Reduced 12.12%
1,436 $525,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $192,712 - $219,615
650 Added 66.06%
1,634 $528,000
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $24,528 - $28,799
88 Added 9.82%
984 $319,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $1,408 - $1,749
-6 Reduced 0.67%
896 $257,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $202,814 - $251,694
902 New
902 $249,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $991,668 - $1.17 Million
-13,363 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $277,448 - $297,595
3,386 Added 33.94%
13,363 $1.13 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $768,927 - $853,432
9,977
9,977 $853,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.